2026-01-27 - Analysis Report
**Stock Overview**
----------------

Palantir Technologies Inc., or Palantir, is a company that develops and sells data analytics platforms, including data integration and data warehousing.

**Return Rate Comparison**
-------------------------

* Cumulative return of review stock (PLTR): 871.70%
* Cumulative return of comparison stock (S&P 500, VOO): 89.89%
* Divergence (max: 1033.00, min: -70.40, current: 795.50, relative divergence: 78.50%)

The review stock has a significantly higher cumulative return compared to the comparison stock, indicating a higher return rate. However, the relative divergence is at 78.50%, which is not at the maximum fluctuation range of 100%.

**Alpha, Beta Analysis**
-------------------------

| Year      | CAGR | MDD  | Alpha | Beta | Cap(B) |
|-----------|------|------|-------|------|-------|
| 2021-2023 | -170.0% | 60.7% | -188.0% | 2.0 | 40.9B |
| 2022-2024 | 445.0% | 50.1% | 415.0% | 2.2 | 180.3B |
| 2023-2025 | 974.0% | 40.2% | 899.0% | 2.3 | 423.7B |

The review stock has high CAGR and MDD values in the 2022-2024 period, indicating high returns and risk. The alpha value is negative in the 2021-2023 period, but positive in the 2022-2024 period, indicating outperformance. The beta value is high in all periods, indicating high volatility.

**Recent Stock Price Fluctuations**
--------------------------------

* Close: $167.47
* Last-market: -1.26%
* 5-day SMA: $167.37
* 20-day SMA: $175.54
* 60-day SMA: $178.98

The review stock has a slightly lower close price compared to the last market price, indicating a small decline. The 5-day SMA is similar to the close price, while the 20-day and 60-day SMAs are higher, indicating an upward trend.

**RSI, PPO Index Indicators**
-----------------------------

* MRI: 0.70
* RSI: 40.74
* PPO: -0.72
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.70)

The MRI value indicates a medium-risk investment. The RSI value is below 50, indicating an oversold stock. The PPO value is negative, indicating a downtrend. The hybrid signal is a buy signal, but with no cash allocation.

**Recent News & Significant Events**
----------------------------------

* [2026-01-25] Palantir Stock for the Next 10 Years: Buy, Hold, or Avoid? - The Motley Fool
* [2026-01-23] Palantir Technologies (PLTR) Stock Trades Up, Here Is Why - TradingView
* [2026-01-23] Top analyst revisits Palantir price target ahead of earnings - thestreet.com
* [2026-01-23] The Case For Palantir Stockâ€™s Next Rally - Forbes
* [2026-01-21] Palantir Technologies (NASDAQ: PLTR) Stock Price Prediction for 2026: Where Will It Be in 1 Year - 24/7 Wall St.
* [2026-01-26] Should You Buy the Dip in Palantir Stock? - The Motley Fool

These recent news and events suggest a positive outlook for the review stock, with some analysts recommending a buy or hold.

**Analyst Opinions**
-------------------

Analyst Consensus:
- Key: Hold
- Mean (1=StrongBuy~5=Sell): 2.81 (~Hold)
- Opinions: 24
- Target Price (avg/high/low): 190.25 / 255.00 / 50.00

The analyst consensus is a hold rating, with a mean opinion score of 2.81, indicating a neutral outlook. The target price range is wide, with an average target price of 190.25.

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
|------|-----|---------|
| 2025-11-04 | 0.2 | 1.18 B$ |
| 2025-08-05 | 0.14 | 1.00 B$ |
| 2025-05-06 | 0.09 | 0.88 B$ |
| 2024-11-05 | 0.06 | 0.73 B$ |
| 2025-11-04 | 0.06 | 0.73 B$ |

The review stock has shown positive earnings per share (EPS) growth, with a high revenue growth in the 2025-11-04 period. The EPS values have increased over time, indicating a positive earnings trend.

**Financial Information**
------------------------

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.18B | 82.45% |
| 2025-06-30 | $1.00B | 80.78% |
| 2025-03-31 | $0.88B | 80.43% |
| 2024-12-31 | $0.83B | 78.91% |
| 2024-09-30 | $0.73B | 79.79% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $6.59B | 7.22% |
| 2025-06-30 | $5.93B | 5.51% |
| 2025-03-31 | $5.42B | 3.95% |
| 2024-12-31 | $5.00B | 1.58% |
| 2024-09-30 | $4.50B | 3.19% |

The review stock has shown a high profit margin and revenue growth over the past few quarters. The equity value has increased, and the return on equity (ROE) values have also increased, indicating a positive return on assets.

**Comprehensive Analysis**
-------------------------

Based on the analysis, the review stock has shown:

* A significantly higher cumulative return compared to the comparison stock
* High CAGR and MDD values in the 2022-2024 period
* Positive EPS growth and revenue growth
* A high profit margin and revenue growth over the past few quarters
* A positive ROI and return on equity values

However, the review stock also has:

* A high beta value, indicating high volatility
* A negative PPO value, indicating a downtrend
* A risk level of medium, indicating a need for caution

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.